Tag

Mrna Vaccine

All articles tagged with #mrna vaccine

AI Aims to Spot Pancreatic Cancer Years Before Diagnosis
technology23 days ago

AI Aims to Spot Pancreatic Cancer Years Before Diagnosis

Researchers describe a trio of advances against pancreatic cancer: a drug targeting a key cancer-driving gene, a personalized mRNA vaccine, and an AI imaging tool that can flag cancer years earlier than typical diagnoses. A Mayo Clinic study suggests the AI system could detect pancreatic cancer up to three years before diagnosis, with about 85% overall accuracy and sensitivity higher than radiologists in earlier scans. While promising, experts caution that such tools must be applied to high‑risk populations to avoid false positives and that more work is needed before broad clinical adoption.

Personalized mRNA Vaccine Sparks Long-Term Survival in Pancreatic Cancer
science1 month ago

Personalized mRNA Vaccine Sparks Long-Term Survival in Pancreatic Cancer

At the AACR meeting, researchers report a phase 1 trial of a patient-specific mRNA vaccine for pancreatic cancer, made from each patient's tumor material after surgery and used with immunotherapy and chemotherapy. Eight patients showed immune responses, and seven of these responders were alive up to six years post-surgery, with about 90% of responders remaining alive at follow-up. While promising, the findings come from a small early trial, and a global phase 2 study is now underway to assess broader efficacy.

Personalized mRNA cancer vaccine sparks lasting response in pancreatic cancer trial
health1 month ago

Personalized mRNA cancer vaccine sparks lasting response in pancreatic cancer trial

A small Phase 1 trial of personalized mRNA vaccines given after surgical removal of operable pancreatic cancer and standard chemo shows that after nine doses, several patients mounted a durable T-cell–driven immune response. Six years of follow-up indicate that some responders remain alive and cancer-free, suggesting potential long-term benefit, though the results are early and come from a limited group as researchers move to a larger Phase 2 study.

AI-designed mRNA vaccine shrinks dog's cancer, fueling hopes for human treatment
technology2 months ago

AI-designed mRNA vaccine shrinks dog's cancer, fueling hopes for human treatment

An AI-assisted effort led to an mRNA vaccine that halved a dog’s mast cell tumor during a Sydney trial. The owner used a chatbot to brainstorm therapies and then worked with UNSW scientists who DNA-sequenced the tumor to tailor the vaccine. While the result is promising for pets and could inform human cancer research, experts caution against hype and note that more evidence is needed before any broader claims.

AI-designed mRNA vaccine shrinks a dog’s cancer in world-first study
science2 months ago

AI-designed mRNA vaccine shrinks a dog’s cancer in world-first study

A Sydney tech entrepreneur used ChatGPT to help design a personalised mRNA cancer vaccine for his rescue dog Rosie. After sequencing Rosie’s tumour and collaborating with UNSW researchers, they produced a bespoke vaccine that, after December and January injections, halved the tumour and improved her quality of life. Described as the first canine personalised cancer vaccine, the work raises hope for human applications, though ethical approvals, costs, and partial responses mean it is not a cure yet and more testing is planned.

Tailored mRNA vaccines spark durable T cell immunity in adjuvant TNBC
science3 months ago

Tailored mRNA vaccines spark durable T cell immunity in adjuvant TNBC

A phase study in 14 women with adjuvant-treated triple-negative breast cancer shows individualized neoantigen mRNA–LPX vaccines encoding up to 20 mutations elicit robust, multi-epitope CD4+/CD8+ T cell responses that persist for years and correlate with relapse-free outcomes in most patients (up to ~6 years). Vaccinated T cells differentiate into cytotoxic, late-stage effector and stem-like memory (TSCM) phenotypes, with durable clonal lineages detected long after vaccination. Three relapses occurred due to weak responses, MHC I loss, or a genetically distinct recurrent tumor. The findings demonstrate the feasibility of on-demand personalized RNA vaccines and provide insights into immune escape and memory formation to guide future immunotherapy strategies.

Toward a world without flu: universal vaccines gain ground
future-perfect4 months ago

Toward a world without flu: universal vaccines gain ground

The current flu season is unusually harsh with high illness and hospitalization numbers and low vaccination rates, but researchers are pursuing a set of universal flu vaccine approaches (targeting the HA stem, mosaic nanoparticle displays, and neuraminidase/T-cell–based strategies) plus longer-lasting preventives. If these efforts succeed and are paired with faster vaccine updates, the world could see dramatically reduced infections and severe illnesses in future winters, though funding and public acceptance remain challenges.

Could COVID-19 mRNA Vaccines Pave the Way for Universal Cancer Treatment
health6 months ago

Could COVID-19 mRNA Vaccines Pave the Way for Universal Cancer Treatment

A study from the University of Florida suggests that an experimental mRNA vaccine, combined with existing immunotherapies, could broadly stimulate the immune system to recognize and destroy various cancers, potentially leading to universal cancer prevention and treatment strategies. The vaccine activates immune responses that not only target tumors but also promote immune memory and epitope spreading, offering hope for more effective, off-the-shelf cancer therapies and preventive vaccines. However, these findings are based on mouse models, and human trials are needed to confirm safety and efficacy.

Advances in Cancer Vaccines and mRNA Therapeutics Show Promising Breakthroughs
healthcare10 months ago

Advances in Cancer Vaccines and mRNA Therapeutics Show Promising Breakthroughs

Researchers at the University of Florida have developed a promising experimental mRNA-based vaccine that could lead to a universal cancer vaccine, boosting the immune system to fight various cancers and potentially replacing traditional treatments like surgery and chemotherapy. The vaccine works by stimulating immune responses, including increasing PD-L1 proteins on cancer cells, making tumors more vulnerable to immune attack. While still in early stages and tested in mice, this approach could revolutionize cancer treatment if successful in humans.

Scientists Develop mRNA Vaccine Toward Universal Cancer Cure
science10 months ago

Scientists Develop mRNA Vaccine Toward Universal Cancer Cure

Recent science news includes a study showing that an mRNA vaccine can make tumors more responsive to immunotherapy, research indicating dogs' interest in TV varies with personality, a reconstruction of prehistoric ribcages suggesting climate influences evolution, a first observation of the transverse Thompson effect, and a study debunking the old nursery rhyme about children's birth days.